UpdatesPress Release

Caplin Point's subsidiary, Caplin Steriles, secured USFDA approval for Foscarnet Sodium Injection.

Caplin Point Laboratories Limited logo
Caplin Point Laboratories LimitedCAPLIPOINT · Filed with the exchange

This generic targets a US market with annual sales of ~$15 million, enhancing future revenue opportunities.

Read the original filing(PDF)

No comments yet. Be the first.

More from Caplin Point Laboratories Limited

All announcements